![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
Pfizer Inc said a combination of its breast cancer drug, Ibrance, and another drug was not statistically significant in extending overall survival in certain patients, the secondary goal of a late-stage trial.
Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2
Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg doses of dulaglutide, revealing that all three provided...
NHS could save £7 billion via new diagnostic techniques
Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) has revealed that the NHS could save over £6.9 billion in five years through quick adoption of new diagnostic tests.
Kallyope and Novo Nordisk announce obesity and diabetes collaboration
Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the treatment of obesity and diabetes.
Study finds growing support to allow pharmacists to write prescriptions
Prescribing of medications has traditionally been restricted to physicians, but there is growing support to allow pharmacists to do so as well.
Latecomer Sanofi looks to catch next wave of cancer therapies
Sanofi missed the boat on immune system-boosting cancer drugs. Now it’s trying to catch up.
Boehringer Ingelheim expands European Metacam indication to guinea pigs
Boehringer Ingelheim adds a new species to its Metacam (active ingredient: meloxicam) brand in Europe, expanding the indications of this widely used analgesic and anti─inflammatory medicine to guinea pigs.
Europese Commissie benoemt denktank AI
De Europese Commissie stelt een groep van vijftig topexperts aan om te helpen bij de beeldvorming en regelvorming rondom kunstmatige intelligentie. Ze gaan ook nadrukkelijk werken aan ethische regels.
Roche to pay $2.4 billion to buy rest of Foundation Medicine
Swiss drugmaker Roche Holding AG has agreed to pay $137 per share to buy the rest of Foundation Medicine (FMI) , a $2.4 billion transaction that values the U.S. genomic profiling group at $5.3 billion, the partners said.
Scientists develop novel computational framework to support personalized cancer treatment
Researchers at Columbia University Irving Medical Center have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug...
Global pharmaceutical excipients market size expected to surge 6.87% by 2026: Research And Markets
The global pharmaceutical excipients market was valued at USD 6,615.7 million in 2017 and expected to reach USD 11,938.1 million by 2026 expanding at a CAGR of 6.87 per cent from 2018 to 2026.
J&J looks to trim business with $2.8bn sale
Johnson & Johnson continues to look at options to slim down its business, after having received an offer from Fortive to sell its medical-sterilisation unit for $2.8 billion.
Pfizer pumps $600m into venture fund, targeting neuroscience
Pfizer’s move to dump it’s neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an end of big pharma’s interest in the notoriously difficult to target disease area...
‘Er zijn meer proefpersonen nodig om medicijnen te testen’
De vraag naar medicijntesters in Nederland stijgt. Grote klinieken zijn hard op zoek naar proefpersonen die in ruil voor soms wel duizenden euro’s geneesmiddelen willen testen.
Axovant attempts to rise from ashes with $842m Parkinson’s therapy deal
Axovant’s spectacular crash to Earth, after a soaring IPO that saw its share price hit the heady heights of $26, is likely to become a biotech cautionary tale into the future but the next twist in the tale was revealed...
Mylan lands biosimilar sucker punch to Amgen’s blockbuster
Mylan and Biocon have received FDA approval for their biosimilar to Amgen’s Neulasta (pegfilgrastim), setting the companies on track to snatch a chunk of the treatment’s $4.2 billion per year in sales, as recorded last...
Short copy voor smartphones: 5 tips voor mobile marketing
Anno 2018 is er bijna niemand meer die zijn smartphone níet overal mee naartoe neemt. Als jij klanten benadert via mobiel, is de kans dus groot dat jouw berichtje meteen wordt gezien. Maar mobiele communicatie (via...
UK Institute to harness disruptive technology to transform drug discovery
Business Secretary Greg Clark today announced funding for a series of ambitious technology projects that will transform the way medicines are discovered, enabling the pharmaceutical industry to develop groundbreaking...
